Keywords: Eurand, Axan, M&A

Eurand agrees to around $583 million acquisition by Axcan

Article | 02 December 2010

Print This

Dutch specialty pharmaceutical company, Eurand NV (Nasdaq: EURX) has agreed to be acquired by privately-held US firm Axcan Holdings, which ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in